Akero Therapeutics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC AKRO

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/14/2025

Shares

99,917

Value ($000)

4,744

Weight

0.0%

2020 Q3 - 2025 Q3 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/14/2025	4,744	0.0%	99,917	9/30/2025
2025 Q2	8/14/2025	8,621	0.0%	161,565	6/30/2025
2025 Q1	5/19/2025	4,449	0.0%	109,909	3/31/2025
2024 Q4	2/14/2025	1,988	0.0%	71,451	12/31/2024
2024 Q3	11/14/2024	1,733	0.0%	60,416	9/30/2024
2024 Q2	8/14/2024	1,539	0.0%	65,614	6/30/2024
2024 Q1	5/15/2024	1,176	0.0%	46,539	3/31/2024
2023 Q4	2/14/2024	1,087	0.0%	46,539	12/31/2023
2023 Q3	11/13/2023	2,354	0.0%	46,539	9/30/2023
2023 Q2	8/11/2023	1,457	0.0%	38,090	6/30/2023
2023 Q1	5/15/2023	1,457	0.0%	38,090	3/31/2023
2022 Q4	2/14/2023	1,971	0.0%	35,969	12/31/2022
2022 Q3	11/14/2022	838	0.0%	24,609	9/30/2022
2022 Q2	8/12/2022	320	0.0%	33,872	6/30/2022
2022 Q1	5/16/2022	265	0.0%	18,640	3/31/2022
2021 Q1	5/14/2021	212	0.0%	7,300	3/31/2021
2020 Q4	3/1/2021	217	0.0%	8,400	12/31/2020
2020 Q3	11/13/2020	259	0.0%	8,400	9/30/2020